ARGENX SE is 11.0x more valuable than CG Oncology, Inc. by market capitalization ($53.35 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | ARGX |
|---|---|---|
| Market cap | $4.84 B | $53.35 B |
| US-listed rank | #1405 | #306 |
| Net income (latest FY) | -$161.00M | - |
| SEC filings | 189 | 272 |
ARGENX SE is 11.0x more valuable than CG Oncology, Inc. by market capitalization ($53.35 B vs $4.84 B).
Full pages: CG Oncology, Inc. and ARGENX SE, or browse the full rankings.